Contrarian investing advice from biotech and pharmaceutical stock expert Hartaj Singh, Founding Partner of Tecumseh Partners ...

Needless to say, we’ve been experiencing some volatility, some uncertainty in the investment markets. I thought a good place to start would be, from your vantage point, what has the impact or ...

I thought a good place to start would be with you, Craig, telling our readers a bit about Icon Advisers, the company overall and what the business looks like today. It’s almost 40 years ago that you ...

Complete Access to New Interviews, the Archive, and all Special Reports.

PAUL H. RISS is CEO and CFO of eLEC Communications Corp. Mr. Riss originally served the company in 1995 as an independent member of the Board of Directors. After joining the company in 1996, he ...

Justin Montminy, CFA, is a Portfolio Manager for the quantitative equity funds and a Quantitative Analyst on the quantitative equity team at Voya Investment Management. Prior to joining Voya, he ...

TWST: Introduce our readers to R5 Capital by telling us a bit about the business overall.

Let’s start with an introduction of sorts to CS McKee — your overall business, portfolios, and investment approach — before we get into a specific fund. Mr. Thompson: At CS McKee, we’re primarily an ...

For our readers, let’s start with some introductory information about Phocas Financial, an overview of the firm’s history and what the business looks like today. Ms. Foreman: Phocas is an ...